Trivalent Baculovirus-expressed Influenza HA vaccine

BIOLOGICAL3 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), M.D. Anderson Cancer Center

Conditions

InfluenzaLymphoma

Phase 2

Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma

CompletedNCT00307177

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2004-08-31End: 2005-04-30Updated: 2014-12-05

Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma

CompletedNCT00307710

M.D. Anderson Cancer CenterLymphoma

Start: 2004-08-31End: 2007-02-28Updated: 2012-07-31

High Dose Influenza in Immunosuppressed Subjects

WithdrawnNCT00766285

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

End: 2010-09-30Updated: 2015-08-03